Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Lan-Ping Xu

Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients With Intermediate-Risk Acute Myelogenous Leukemia in First Complete Remission

Clinical Cancer Research

Cancer Research

Oncology

2018

English

Immunosuppressant Indulges EBV Reactivation and Related Lymphoproliferative Disease by Inhibiting Vδ2+ T Cells Activities After Hematopoietic Transplantation for Blood Malignancies

Journal for ImmunoTherapy of Cancer

English

Who Is the Best Haploidentical Donor for Acquired Severe Aplastic Anemia? Experience From a Multicenter Study

Journal of Hematology and Oncology

English

N-Acetyl-L-Cysteine Improves Bone Marrow Endothelial Progenitor Cells in Prolonged Isolated Thrombocytopenia Patients Post Allogeneic Hematopoietic Stem Cell Transplantation

American Journal of Hematology

Hematology

2018

English

Effects of Pre- And Post-Transplantation Minimal Residual Disease on Outcomes in Pediatric Patients With Acute Myeloid Leukemia Receiving Human Leukocyte Antigen-Matched or Mismatched Related Donor Allografts

American Journal of Hematology

Hematology

2017

English

Impairment of Bone Marrow Endothelial Progenitor Cells in Acute Graft-Versus-Host Disease Patients After Allotransplant

British Journal of Haematology

Hematology

2018

English

An Unbalanced Monocyte Macrophage Polarization in the Bone Marrow Microenvironment of Patients With Poor Graft Function After Allogeneic Haematopoietic Stem Cell Transplantation

British Journal of Haematology

Hematology

2018

English

Nonmalignant Late Effects in Survivors of Partially Matched Donor Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2013

English

Effects of Low-Dose Glucocorticoid Prophylaxis on Chronic GVHD and GVHD-free, Relapse-Free Survival After Haploidentical Transplantation: Long-Term Follow-Up of a Controlled, Randomized Open-Label Trial

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2019

English

Corrigendum to ‘Interferon Α: A Potentially Effective Treatment for Minimal Residual Disease in Acute Leukemia/Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation’ [Biology of Blood and Marrow Transplantation 21/11 (2015) 1939-1947]

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2020

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Lan-Ping Xu

Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients With Intermediate-Risk Acute Myelogenous Leukemia in First Complete Remission

Immunosuppressant Indulges EBV Reactivation and Related Lymphoproliferative Disease by Inhibiting Vδ2+ T Cells Activities After Hematopoietic Transplantation for Blood Malignancies

Who Is the Best Haploidentical Donor for Acquired Severe Aplastic Anemia? Experience From a Multicenter Study

N-Acetyl-L-Cysteine Improves Bone Marrow Endothelial Progenitor Cells in Prolonged Isolated Thrombocytopenia Patients Post Allogeneic Hematopoietic Stem Cell Transplantation

Effects of Pre- And Post-Transplantation Minimal Residual Disease on Outcomes in Pediatric Patients With Acute Myeloid Leukemia Receiving Human Leukocyte Antigen-Matched or Mismatched Related Donor Allografts

Impairment of Bone Marrow Endothelial Progenitor Cells in Acute Graft-Versus-Host Disease Patients After Allotransplant

An Unbalanced Monocyte Macrophage Polarization in the Bone Marrow Microenvironment of Patients With Poor Graft Function After Allogeneic Haematopoietic Stem Cell Transplantation

Nonmalignant Late Effects in Survivors of Partially Matched Donor Hematopoietic Stem Cell Transplantation

Effects of Low-Dose Glucocorticoid Prophylaxis on Chronic GVHD and GVHD-free, Relapse-Free Survival After Haploidentical Transplantation: Long-Term Follow-Up of a Controlled, Randomized Open-Label Trial

Corrigendum to ‘Interferon Α: A Potentially Effective Treatment for Minimal Residual Disease in Acute Leukemia/Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation’ [Biology of Blood and Marrow Transplantation 21/11 (2015) 1939-1947]